Medicure Incorporated (TSXV: MPH, OTC: MCUJD.PK), a pharmaceutical company, announced yesterday that it has named Dr Neil Owens as its new President and Chief Operating Officer, effective 1 July 2019.
Owens will be responsible for implementing the company's strategic plans, and managing day-to-day operations, including the advancement and management of new and existing pharmaceutical products.
Owens has worked at Medicure since 2014, serving most recently as Director, Scientific Affairs. Owens holds a Bachelor of Science and a PhD in Chemistry from the University of Manitoba and has Post Doctoral experience with the IECB.
POLYTECH Health & Aesthetics announces Poland expansion
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar
Novo Nordisk expands legal action over compounded 'semaglutide'
Neuraxpharm launches Neuraxpharm Australia
OncoZenge selects Meribel Pharma as CDMO for Phase 3 BupiZenge project
Fridays nominated for World Out of Home awards for weight loss campaign
Physiomics expands into biometrics with two contract wins and new division head
DELFI Diagnostics CTO receives 2025 Most Influential Women in Bay Area Business recognition
Clario acquires imaging provider NeuroRx
Healthcare Holding Schweiz AG acquires Effectum CH-Rep AG to expand services
iOncologi acquires TargImmune Therapeutics
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval